Department of Microbiology, School of Medicine, Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
J Appl Genet. 2023 May;64(2):367-373. doi: 10.1007/s13353-023-00757-9. Epub 2023 Mar 28.
Escherichia coli sequence type 131 (ST131) is a multidrug-resistant strain with the global dissemination. Biofilm formation-related factors include the most important virulence factors in extra-intestinal pathogenic E. coli (ExPEC) ST131 strains causing infections with treatment-limited subjects. This study aims to investigate the biofilm formation ability and its correlation with the presence of fimH, afa, and kpsMSTII genes in clinical isolates of ExPEC ST131. In this regard, the prevalence and characteristics of these strains collected and evaluated. The results revealed strong, moderate, and weak attachment abilities related to biofilm formation attributes in 45%, 20%, and 35% of strains, respectively. In the meantime, the frequency of the fimH, afa, and kpsMSTII genes among the isolates was observed as follows: fimH positive: 65%; afa positive: 55%; and kpsMSTII positive: 85%. The results convey a significant different of biofilm formation ability between clinical E. coli ST131 and non-ST131 isolates. Furthermore, while 45% of ST131 isolates produced strong biofilms, only 2% of non-ST131 isolates showed the ability to form strong biofilms. The attending of fimH, afa, and kpsMSTII genes in the majority of ST131 strains demonstrated a key role leading to biofilm formation. These findings suggested the application of fimH, afa, and kpsMSTII gene suppressors for treating biofilm infections caused by drug-resistant ST131 strains.
大肠埃希菌 131 型序列(ST131)是一种具有全球传播能力的多药耐药菌株。生物膜形成相关因素包括肠外致病性大肠埃希菌(ExPEC)ST131 菌株中最重要的毒力因子,这些菌株引起的感染治疗受限。本研究旨在调查临床分离的 ExPEC ST131 菌株的生物膜形成能力及其与 fimH、afa 和 kpsMSTII 基因存在的相关性。为此,收集和评估了这些菌株的流行情况和特征。结果表明,在 45%、20%和 35%的菌株中,生物膜形成属性的附着能力分别为强、中、弱。同时,fimH、afa 和 kpsMSTII 基因在分离株中的频率如下:fimH 阳性:65%;afa 阳性:55%;和 kpsMSTII 阳性:85%。结果表明,临床大肠杆菌 ST131 与非 ST131 分离株的生物膜形成能力存在显著差异。此外,虽然 45%的 ST131 分离株产生强生物膜,但只有 2%的非 ST131 分离株具有形成强生物膜的能力。fimH、afa 和 kpsMSTII 基因在大多数 ST131 菌株中的存在表明其在生物膜形成中起着关键作用。这些发现表明,应用 fimH、afa 和 kpsMSTII 基因抑制剂来治疗耐药性 ST131 菌株引起的生物膜感染。